音楽とガイド付きマインドフルネスの心血管効果 (CMM)
音楽とガイド付きマインドフルネスの心血管効果:無作為化クロスオーバー試験
The purpose of this study is to examine how listening to music compares to guided mindfulness in affecting blood pressure, heart rate, and feelings of anxiety in healthy adults. The investigators aim to determine whether one of these approaches is more effective in reducing these variables. Additionally, the study will explore whether personal traits or preferences, measured using questionnaires, influence how participants respond to music or mindfulness. Based on previous clinical findings, the researchers hypothesize that listening to music will lead to greater reductions in blood pressure and heart rate compared to guided mindfulness.
調査の概要
詳細な説明
Music and mindfulness-based practices, such as meditation and breathing exercises, are well-established non-pharmacological interventions known to positively influence both physiological and psychological health. They are utilized for their ability to reduce stress and promote relaxation by modulating autonomic nervous system activity, which in turn influences the cardiovascular system. This modulation has been associated with reductions in markers of physiological stress, such as blood pressure and heart rate.
Cardiovascular influences of music and mindfulness have been leveraged in numerous medical procedures for enhancing comfort and tolerability, as well as mental well-being. However, despite the widespread use and documented physiological effects of music and mindfulness-based interventions, there is a lack of research directly comparing their effects. Furthermore, there is a relative lack of high-quality randomized trials examining the effects of music and mindfulness on parameters such as blood pressure and heart rate.
This randomized crossover study will examine the cardiovascular impact of listening to a curated music playlist versus participating in a guided mindfulness session in a healthy population to determine whether music produces greater reductions in blood pressure and heart rate than guided mindfulness.
Each participant will attend a single 3-hour study visit, during which they will take part in two sessions. One session involves listening to a carefully selected music playlist, and the other involves participating in a guided mindfulness exercise. The order of the sessions will be random. Blood pressure and heart rate will be measured throughout the study visit, and participants will be asked to complete questionnaires measuring anxiety, experience with music and mindfulness, tendency to become deeply engaged, and enjoyment of each session.
The primary aim is to compare changes in systolic blood pressure, diastolic blood pressure, and heart rate between curated music playlist and guided mindfulness interventions, using an automated oscillometric upper arm blood pressure monitor with measurements taken at 10-minute intervals.
By investigating the physiological effects of music versus guided mindfulness on hemodynamic responses in a healthy population, this study will provide critical insight into the distinct and shared autonomic effects of these two non-pharmacological interventions. Understanding the cardiovascular effects of music and guided mindfulness will inform evidence-based guidelines for integrating these interventions into clinical and research protocols. As non-invasive therapeutic tools, both music and mindfulness hold promise for enhancing patient care across diverse settings.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Quebec
-
Montreal、Quebec、カナダ、H3T 1E2
- Jewish General Hospital
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Normal baseline blood pressure (systolic BP < 120 mmHg and diastolic BP < 80mmHg).
- Abstention from caffeine intake for at least 12 hours before the study session and throughout the session, as caffeine may influence cardiovascular measurements.
- Abstention from using nicotine or tobacco products for at least 1 hour before the study session and throughout the session, as these substances may influence cardiovascular measurements.
Exclusion Criteria:
- Significant hearing impairments that cannot be improved with hearing aids or sound amplification.
- Current use of medications that could affect blood pressure.
- History of hypertension or cardiovascular disease.
- Diagnosis of active substance use disorder, or reported patterns of alcohol, cannabis, or recreational/non-prescribed substance use likely to affect cardiovascular function.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:基礎科学
- 割り当て:ランダム化
- 介入モデル:クロスオーバー割り当て
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Music Intervention First
Participants randomized to this arm will receive a 40-minute Music Listening intervention in the first period, followed by a 20-minute washout period, and then receive a 40-minute Guided Mindfulness intervention in the second period. |
Participants will listen to a 40-minute playlist, curated by the research team, through noise-cancelling headphones. The playlist will simultaneously be played in the room through speakers. Participants will engage in a structured mindfulness session led by a member of the research team with experience in mindfulness-based practices. |
|
実験的:Mindfulness Intervention First
Participants randomized to this arm will receive a 40-minute Guided Mindfulness intervention in the first period, followed by a 20-minute washout period, and then receive a 40-minute Music Listening intervention in the second period. |
Participants will listen to a 40-minute playlist, curated by the research team, through noise-cancelling headphones. The playlist will simultaneously be played in the room through speakers. Participants will engage in a structured mindfulness session led by a member of the research team with experience in mindfulness-based practices. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Changes in Blood Pressure
時間枠:0, 10, 20, 30, and 40 minutes during each 40-minute intervention session.
|
The investigators will compare changes in systolic and diastolic blood pressure between the curated music playlist and guided mindfulness interventions using an automated oscillometric upper arm blood pressure monitor with measurements taken at 10-minute intervals. |
0, 10, 20, 30, and 40 minutes during each 40-minute intervention session.
|
|
Changes in Heart Rate
時間枠:0, 10, 20, 30, and 40 minutes during each 40-minute intervention session.
|
The investigators will compare changes in heart rate between the curated music playlist and guided mindfulness interventions using an automated oscillometric upper arm blood pressure monitor with measurements taken at 10-minute intervals. |
0, 10, 20, 30, and 40 minutes during each 40-minute intervention session.
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Changes in Beat-to-Beat Blood Pressure (Finapres NOVA)
時間枠:0 to 40 minutes during each 40-minute intervention session.
|
Continuous beat-to-beat blood pressure will be recorded using Finometer Model 2 hemodynamic monitoring technology (Finapres Medical Systems, Netherlands) to allow for more detailed characterization of the cardiovascular response to music and mindfulness, potentially capturing effects on systolic and diastolic blood pressure not detected by periodic arm-cuff measurements. |
0 to 40 minutes during each 40-minute intervention session.
|
|
Changes in Heart Rate (Finapres NOVA, Electrocardiogram-derived)
時間枠:0 to 40 minutes during each 40-minute intervention session.
|
Heart rate will be recorded continuously using the electrocardiogram (ECG) channel of the Finapres NOVA, a non-invasive continuous hemodynamic monitoring technology (Finapres Medical Systems, Netherlands). Heart rate values will be derived from the ECG signal. This will allow for more detailed characterization of the cardiovascular response to music and mindfulness, potentially capturing effects on heart rate not detected by periodic arm-cuff measurements. |
0 to 40 minutes during each 40-minute intervention session.
|
|
Change from Baseline in STAI-Y 1
時間枠:Baseline and immediately after each of the two 40-minute intervention sessions during the single study visit.
|
The investigators will measure changes in acute anxiety using the State-Trait Anxiety Scale (STAI) - State subscale (form Y1) before and after each intervention. The STAI consists of 20 participant-rated statements, from 1 to 4 (1= Not at all, 4= Very much so) regarding their current anxiety (state). A lower score corresponds to less severity of symptoms. |
Baseline and immediately after each of the two 40-minute intervention sessions during the single study visit.
|
|
Change from Baseline in Edmonton Symptom Assessment System (ESAS)
時間枠:Baseline and immediately after each of the two 40-minute intervention sessions during the single study visit.
|
The investigators will measure changes in common symptoms using the ESAS before and after each intervention. The ESAS consists of 10 common symptoms: pain, tiredness, drowsiness, nausea, appetite, shortness of breath, depression, anxiety, well-being, and other, rated from 0 to 10. A lower score corresponds to less severity of symptoms. |
Baseline and immediately after each of the two 40-minute intervention sessions during the single study visit.
|
|
Barcelona Music Reward Questionnaire (BMRQ)
時間枠:Baseline
|
The Barcelona Music Reward Questionnaire (BMRQ) is a validated 20-item questionnaire used to assess individual differences in the rewarding aspects of music listening. Each item is a statement rated on a 5-point Likert scale (1 = "Completely Disagree" to 5 = "Completely Agree"). Higher scores indicate a greater sensitivity to music-related reward. The total and subscale scores will be used to determine whether the extent of music reward experienced by participants predicts the magnitude of cardiovascular impact. |
Baseline
|
|
MUSE questionnaire
時間枠:Baseline
|
The MUSE questionnaire includes two quantitative items assessing average weekly and daily hours of music listening, as well as three 5-point Likert scale items evaluating the subjective importance of music, frequency of listening, and preference for specific genres. It will be used to characterize participants' music listening habits and attitudes and their relationship to cardiovascular outcomes. |
Baseline
|
|
Mindfulness Adherence Questionnaire (MAQ)
時間枠:Baseline
|
The Mindfulness Adherence Questionnaire (MAQ) is designed to measure the quantity and quality of an individual's mindfulness practice. It includes two quantitative items assessing frequency of formal practice and average duration of each session, as well as ten 5-point Likert scale items evaluating quality of mindfulness practice and time spent being mindful in everyday life, outside of formal sessions. It will be used to evaluate participants' experience with mindfulness and its relationship to cardiovascular outcomes. |
Baseline
|
|
Modified Tellegen Absorption Scale (MODTAS)
時間枠:Baseline
|
The Modified Tellegen Absorption Scale (MODTAS) is a validated 34-item questionnaire designed to measure an individual's engagement or immersion in sensory or imaginative experiences. Each item is rated on a 5-point Likert scale. It will be used to explore whether individual differences in trait absorption predict responsiveness to music and mindfulness interventions. |
Baseline
|
|
Subjective Enjoyment (Visual Analogue Scale and Open-Ended Questions)
時間枠:Immediately after each of the two 40-minute intervention sessions during the single study visit.
|
The investigators will assess subjective enjoyment of each intervention using 10-point visual analogue scales (VAS) administered immediately following each session. Participants will rate their enjoyment on a horizontal scale ranging from 0 ("not at all enjoyable") to 10 ("extremely enjoyable"). Additionally, participants will be asked a series of open-ended questions about their experience of each intervention. Including these measures will allow for assessment of potential preference effects that could influence cardiovascular outcomes. |
Immediately after each of the two 40-minute intervention sessions during the single study visit.
|
協力者と研究者
捜査官
- 主任研究者:Kyle Greenway, MD、Sir Mortimer B. Davis - Jewish General Hospital, McGill University
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- 2026-4674
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
Due to the sensitive nature of the data and the small sample size, which poses a risk of participant identification, the data will not be shared.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。